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Abstract
Background: Iron supplementation is employed to treat post-malarial anaemia in environments where iron deficiency is
common. Malaria induces an intense inflammatory reaction that stalls reticulo-endothelial macrophagal iron recycling from
haemolysed red blood cells and inhibits oral iron absorption, but the magnitude and duration of these effects are unclear.
Methodology/Principal Findings: We examined the red blood cell incorporation of oral administered stable isotopes of iron
and compared incorporation between age matched 18 to 36 months old children with either anaemia post-malaria (n=37)
or presumed iron deficiency anaemia alone (n=36). All children were supplemented for 30 days with 2 mg/kg elemental
iron as liquid iron sulphate and administered
57Fe and
58Fe on days 1 and 15 of supplementation respectively.
57Fe and
58Fe
incorporation were significantly reduced (8% vs. 28%: p,0.001 and 14% vs. 26%: p=0.045) in the malaria vs. non-malaria
groups. There was a significantly greater haemoglobin response in the malaria group at both day 15 (p=0.001) and 30
(p,0.000) with a regression analysis estimated greater change in haemoglobin of 7.2 g/l (s.e. 2.0) and 10.1 g/l (s.e. 2.5)
respectively.
Conclusion/Significance: Post-malaria anaemia is associated with a better haemoglobin recovery despite a significant
depressant effect on oral iron incorporation which may indicate that early erythropoetic iron need is met by iron recycling
rather than oral iron. Supplemental iron administration is of questionable utility within 2 weeks of clinical malaria in children
with mild or moderate anaemia.
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Introduction
In endemic countries malaria produces a flux of iron from the
haemolysis of red blood cells in infants and young children many
of whom are already iron deficient. The relative contributions of
malaria and iron deficiency to post-malaria anaemia are often
unclear, however iron supplementation combined with effective
anti-malarial therapy is commonly employed and has been shown
to be an effective strategy for the management of post-malarial
anaemia [1].
Haemolysis, haemoglobin recycling and iron flux are central to
the pathophysiology of malaria and post-malarial anaemia.
Haemoglobin is recycled predominately through reticulo-endo-
thelial macrophages to the bone marrow to fulfill erythropoetic
iron need. Inflammatory insults however inhibit the release of iron
from macrophages [2] and malaria can result in a sequestration of
iron in reticuloendothelial macrophages [3] inhibiting iron
availability to erythroblasts. Inflammation can also result in the
inhibition of oral iron absorption [4] but the magnitude and
duration of this effect after acute malaria are unclear. Malaria does
not cause or exacerbate iron deficiency because iron does not exit
the body in significant amounts, and we hypothesized that
therapeutic supplementation of iron for post-malarial anaemia
may occur in the presence of sequestrated macrophagal iron and
impaired oral absorption. It is unclear how much erythropoetic
iron need is met from recycled haemoglobin or supplemental iron,
for how long the blockade of iron recycling persists, and whether
accompanying iron deficiency stimulates absorption in the child
with malaria in a similar manner to the child with uncomplicated
iron deficiency.
We examined and compared the red cell incorporation of orally
administered stable isotopes of iron and the haemoglobin response
to 30 days of iron supplementation in children anaemic after
malaria and in those with non-malaria anaemia.
Materials and Methods
In The Gambia 76% of children have moderate (,110 g/l) and
15% severe anaemia (,70 g/l) at the end of the malaria season
[5]. Malaria transmission (September to November) mainly occurs
during and immediately after the rainy season and is of moderate
intensity with 1–10 infective bites per person per year (plasmo-
dium falciparum). The malaria season coincides with the ‘hungry’
season when food stores are low when iron deficiency is more
prevalent.
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Anaemic children (haemoglobin ,110 g/l) were recruited from
the MRC Keneba clinic during the malaria season of 2003.
Children between 18 and 36 months of age with anaemia
associated with uncomplicated malaria were recruited from
children who presented with a fever and were found to have a
peripheral parasitemia of greater than 500 parasites per microliter
on Field’s staining of a thick blood film. This was later confirmed
with Giemsa staining. These children were treated with a standard
3 day course of chloroquine (10 mg/kg/day) and fansidar (K
tablet if less than 15 kg body weight once) and were recruited on
the 4
th day after diagnosis when treatment was completed.
Employing haemoglobin at the time of diagnosis as a baseline
when examining the erythropoetic response after malaria is
problematic as haemoglobin can continue to drop during and
after malaria treatment [3]. Well anaemic children between 18
and 36 months of age with no evidence of malaria parasites on
blood film were recruited from either the immunization and
growth monitoring clinic or the general clinic. These children were
recruited if anaemic without a history of fever in the last 7 days
and no medical record of having had a clinical malarial episode
documented or having received anti-malarials during the present
malarial season. Children with severe malnutrition (,23 whz
scores away from reference NCHS 50
th centile) and severe
anaemia (,60 g/l) were excluded from the study. The study
physician saw all children on days 1, 15 and 30 and documented
any clinical symptoms.
All children had a venous blood sample taken on day1 and
day15 and thereafter received
57Fe (3.9 mg on day1) and
58Fe
(1.3 mg on day15) early in the morning after at least a 2 hour
supervised fast. The iron doses were drawn up by needle and
syringe from their respective solutions. The exact weight (Mettle
AM100 scales) of the needle and syringe was detailed before and
after introduction of the isotope into 20 ml of orange juice and
used to calculate the dose of isotope administered to each child.
Thereafter each child was administered a crushed 50 mg vitamin
C tablet in an additional 20 ml of orange juice. All children were
observed for 2 hours after isotope administration and any spillage
or vomiting was recorded. From day 2 all children were supple-
mented daily by a field-worker with 2 mg/kg elemental iron as
liquid iron glycine sulphate (Plesmet Syrup: Universal Products,
Preston, UK) until day 30 when a final venous sample was taken.
No vitamin C was given with the liquid iron glycine sulphate.
Laboratory methodology
Haemoglobin (Hb) (Medonic CA 530 haemoglobinometer) and
zinc protoporphyrin (ZnPP) (Aviv Biomedical haematofluorom-
eter) were measured in The Gambia within 8 hours of sampling
and each sample was assessed for the presence of malaria parasites
as described above. Frozen plasma was transported to the UK for
the analysis of ferritin (Imx ferritin assay based on Microparticle
Enzyme Immunoassay (MEIA) technology, Abbot Laboratories),
soluble transferrin receptors (STfR) (R&D systems ELISA),
erythropoetin (Epo) (R&D systems Quantikine IVD ELISA) and
C reactive protein (CRP)(Dade Dimension particle enhanced
turbidimetric immunoassay).
Stable isotope incorporation methodology
Iron-57 and 58 were converted to an aqueous solution of iron
sulphate as previously described [6]. Isotope ratios were measured
by thermal ionization magnetic sector mass spectrometry [6], [7].
Ratios were expressed relative to the non-administered isotope
iron-56 and corrected for temperature specific differences in
fractionation using the ratio of iron-54 to iron-56. Iron isotope
ratios were converted to tracer:tracee ratios as described elsewhere
[8] and red blood cell incorporation was expressed as percentage
of dose administered.
Ethics and Consent
The clinic of the MRC Keneba field-station has provided free
medical care for local villages for over 25 years. Detailed medical
records of growth and morbidity are maintained for all children
under 3 years of age. The nearest government facility is 20 km
away and it is very unusual for a child from the local villages to
receive treatment outside of the MRC Keneba clinic. The
parents/guardians of children were approached after attendance
at the MRC Keneba clinic for either routine monitoring or after
emergency treatment for malaria. A field-worker not attached to
the clinic team explained the study procedure by reading out an
information sheet in Mandinka. Individual informed consent was
obtained and confirmed by signature/thumbprint. All children
were provided with an insecticide treated bed net on entry to the
study if they did not already sleep under one. The study was
approved by the MRC/Gambian Government Joint Ethics
Committee and the The Institutional Review Board for Baylor
College of Medicine and Affiliated Hospitals in Houston, USA.
Statistics and data analysis
Based on variance data from previous similar studies a sample
size of 38 per group was calculated. We aimed for 90% power to
demonstrate a significant difference (5%) in isotope incorporation
between children with malaria (estimated mean (s.d.) incorpora-
tion 20%+/215%) and children without malaria (estimated mean
(s.d.) incorporation 35%+/225%). Microsoft Access (2000) was
used for data recording and Epi-Info (v6.04) for generation of
nutritional z scores. All data was dual entered with a validation
performed between the two entry records and against the hard
copy of the data. Differences between groups were compared using
t-tests for quantitative variables (or transformed variables) with
approximately normal distributions and chi-squared tests for
categorized variables (SPSS 11.5.0). The strength of trends was
measured by Spearman correlations. A linear regression model of
iron absorption, adjusting for haemoglobin at day1, was used to
compare differences between post-malaria anaemia and non-
malaria anaemia groups and to estimate the marginal means of
loge stable isotope incorporation at day 1 and 15 for the malaria
and non-malaria groups. A multilevel model was utilized to assess
the effects of whz, age, haemoglobin, CRP and iron sufficiency
markers on isotope incorporation independent of day of
administration.
Results
There was no significant difference in age or whz score between
children with post-malarial anaemia (n=37) and those with non-
malaria anaemia (n=36) (Table 1). The malaria group had a
significantly lower mean haemoglobin on day1. All children were
observed to take their daily supplement for 30 days. Children who
either refused to take their stable isotope-labeled iron or who
vomited after administration on day 1 (n=6) or day15 (n=16)
were excluded from analysis of red blood cell incorporation. Six
children (malaria group n=5) who re-presented with fever or
history of fever between days 15 and 30 were found to have a
positive malaria film and were treated.
In the well, non-malaria anaemic group iron deficiency could be
defined retrospectively on the basis of cut-offs in at least 2 of 3 iron
sufficiency markers i.e. STfR .8.5 mg/l [9], ferritin ,12 mg/l
unless CRP .10 mg/l then ,30, and ZnPP .61 mmol/mol
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markers were measured (n=31) in the non-malaria anaemic group
27 fulfilled the criteria for iron deficiency. On days 15, 53 of 70
children with all 3 iron sufficiency markers measured fulfilled the
criteria for iron deficiency. The interpretation of baseline iron
sufficiency markers in the presence of malaria will be discussed.
Analyses of differences in haemoglobin, iron sufficiency marker
measurements and stable isotope incorporation were adjusted for
differences in day1 haemoglobin between groups. There was a
significantly greater haemoglobin response (Figure 1) in the
malaria group at both day15 (p=0.001) and 30 (p,0.001)
compared to the non-malaria group with a regression analysis
estimated greater change in haemoglobin in the malaria group at
day 15 of 7.2 g/l (s.e. 2.0) and at day 30 of 10.1 g/l (s.e. 2.5).
ZnPP, ferritin and STfR but not EPO measurements were all
significantly different (p,0.001) at day1 in the malaria group
(Figures 2–5). ZnPP measurements were high in both groups and
subsequently decreased, associated with iron supplementation, but
remained significantly higher in the non-malaria group at days 15
(p,0.001) and 30 (p,0.001) (Figure 2). Differences in ferritin
measurements decreased between groups by day15 (p=0.016) and
were non-significant by day 30 as measurements normalised.
Ferritin measurements increased with supplementation in the non-
malaria group and decreased in the malaria group as the
inflammatory effect of malaria waned (Figure 3). Differences in
STfR measurements became non-significant by day15 as the
depressant effect of malaria waned and the measurements reduced
towards the normal range in the non-malaria group (Figure 4).
Differences widened again by day 30 (p=0.009) as the malaria
group measurements decreased more rapidly. EPO measurements
fell in both groups associated with supplementation and haemo-
globin response. The fall was more marked in the malaria group
by day15 when measurements were significantly different
(p=0.013).
In a crude analysis, not adjusted for differences in day 1
haemoglobin, red blood cell
57Fe incorporation on day 1 was
significantly lower in the malaria group (malaria: 8.7% (s.e. 1.17),
non-malaria: 26.6% (s.e. 1.15), P,0.001) and remained lower on
day15 for
58Fe incorportion (malaria:15.5% (s.e.1.26), non-
malaria: 24.0% (s.e.1.17), P=0.116). When adjusted for differ-
ences in day 1 haemoglobin both
57Fe and
58Fe incorporation
were significantly reduced between groups (t=25.4, p,0.000 and
t=22.1, p=0.045, respectively). The estimated marginal mean of
57Fe incorporation in the malaria group on day 1 was 8.3% (95%
Table 1. Baseline characteristics (means (S.D.) or geometric
means (S.D.)).
Malaria
Non-malaria
anaemia p
n3 7 3 6 /
Hb (g/l) 83.7 (11.6) 90.6 (12.1) 0.02
Age (years) 2.24 (0.5) 2.29 (0.5) 0.69
Whz 21.4 (0.86) 21.3 (0.8) 0.66
*Soluble transferrin receptors (mg/l) 5.9 (1.5) 8.5 (5.8) ,0.000
*Ferritin (ng/ml) 74.1 (74.8) 5.8 (21.5) ,0.000
*Zinc protoporphyrin (mmol/mol hb) 127 (53) 157 (111) 0.06
*Erythropoetin (miu/ml) 59 (205) 32 (62) 0.02
*geometric means.
doi:10.1371/journal.pone.0002133.t001
Figure 1. Haemoglobin response (mean & 95% CI).
doi:10.1371/journal.pone.0002133.g001
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doi:10.1371/journal.pone.0002133.g002
Figure 3. Loge ferritin measurements (mean & 95% CI). Measurements below 2.5 may be indicative of iron deficiency [10].
doi:10.1371/journal.pone.0002133.g003
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[9].
doi:10.1371/journal.pone.0002133.g004
Figure 5. Loge erythropoetin measurements (mean & 95% CI). Measurements above 2.8 are above the normal range (R&D systems).
doi:10.1371/journal.pone.0002133.g005
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malaria anaemic group. On day 15 the estimated marginal mean
of
58Fe incorporation was 14.4% (95% CI: 9.7–21.1) in the
malaria group versus 25.9% (95% CI: 17.5–38.4) in the non-
malaria anaemic group. When those children that developed
malaria during the study were excluded (n=6 for 7 malaria
episodes of which 5 children were in the post malaria anaemia
group) day 15
58Fe incorporation remained lower in the post
malaria anaemia group (t=1.98, p=0.053).
In the presence of malaria only ferritin (r=20.44, p=0.013)
and crp (r=20.43, p=0.049) correlated with percentage
incorporation and not haemoglobin, whz or other iron markers
(Table 2). Ferritin and CRP were correlated and indicate the
overwhelming effect of malaria-associated inflammation on
isotope incorporation. There was no significant difference between
57Fe incorporation on day1 and
58Fe incorporation on day15 in
the non-malaria group suggesting no evident effect of 14 days prior
iron supplementation on
58Fe incorporation.
Combined group
Data from days 1 and 15 from subjects with non-malarial
anaemia was combined to enhance the power to examine
influences on iron stable isotope incorporation other than malaria
(Table 2). CRP was negatively correlated (r=20.44, p=0.001)
whilst STfR (r=0.29, p=0.028), EPO (r=0.27, P=0.042) and
WHZ (r=0.42, P=0.001) were positively correlated. Neither
ferritin nor haemoglobin correlated significantly with isotope
incorporation. EPO was negatively correlated with Hb (r=20.60,
P,0.001) and positively correlated with both ZnPP (r=0.52,
p,0.001) and STfR (r=0.45, p,0.001). Whz (range –2.6 to 0.8
whz scores) was significantly positively correlated with iron
incorporation but was not correlated with any of the iron
sufficiency markers or CRP. In a multilevel regression model
controlling for day of isotope administration only whz (coeff 1.1,
p,0.001), CRP (coeff 20.69, p=0.001) and ferritin (coeff –0.65,
p=0.020) were independently associated with iron absorption.
Increasing malnutrition was associated with less isotope incor-
poration per kg bodyweight. There was a significant difference in
isotope incorporation between those with a CRP measurement
greater than or less than 10 mg/l (mean (s.d.) 16 (11.5) vs 34.7
(17.7), p,0.001) and between those with a whz score greater than
or less than 21 whz (43.2 (17.2) vs 26.6 (17.8), p=0.001) (Table 3).
Discussion
A standard clinical response to severe post-malarial anaemia is
to supplement with iron and it is a commonly employed
therapeutic strategy in sub-Saharan Africa where endemic iron
deficiency often co-exists. This study was designed to assess the
effect of malaria on the red blood cell incorporation of iron
supplements given to treat post-malarial anaemia. As this study is
one of the largest iron stable isotope incorporation studies carried
out it also allows us to look at the factors affecting iron
incorporation in rural African children.
We have demonstrated a significantly greater haemoglobin
recovery in those children with post-malarial anaemia despite an
Table 2. stable isotope incorporation correlations (number of observations).
Malaria group
Hb Log ferr Log ZnPP Log STfR Log Epo Log CRP
Log Isotope incorp. 20.17(34) 20.43(32)
1 20.02(34) 0.14(32) 0.05(30) 20.35(32)
1
Hb 20.36(35)
1 20.45(37)
2 20.28(35) 20.7 (33)
2 20.15(35)
Log ferritin 0.24(35) 20.42(35)
1 0.6 (33)
2 0.61(35)
2
Log ZnPP 0.12(35) 0.4(33)
1 0.4(35)
1
Log STfR 0.05(33) 20.17(35)
Log Epo 0.42(33)
1
Combined group
Hb Log ferr Log ZnPP Log STfR Log Epo Log CRP
Log Isotope incorp. 20.14(61) 20.22(51) 0.24(59) 0.29(59)
1 0.27(58)
1 20.44(54)
2
Hb 0.09(62) 20.6(70)
2 20.29(70)
1 20.66(69)
2 20.06(64)
Log ferritin 20.15(62) 0.03(62) 20.25(62)
1 0.25(57)
Log ZnPP 0.54(69)
2 0.52(68)
2 20.05(63)
Log STfR 0.45(69)
2 20.08(64)
Log Epo 20.02(64)
The combined non-malaria group represents data of
57Fe absorption on Day 1 and
58Fe absorption on Day 15. All correlations expressed as Spearman coefficients.
1p,0.05.
2p,0.01.
doi:10.1371/journal.pone.0002133.t002
Table 3. Effects of inflammation and whz score on % stable
isotope incorporation (mean (SD) and N) in the combined
57Fe
and
58Fe group.
CRP,10 mg/l CRP.10 mg/l
Whz .21 42.6 (15.1) n=16 24.1 (8.2) n=2 p=0.12
Whz ,21 30.1 (17.7) n=27 14.3 (11.7) n=15 p=0.02
p=0.02 p=0.3
doi:10.1371/journal.pone.0002133.t003
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The reduced incorporation of the oral stable isotope of iron was
most marked at day 1 when the children had completed therapy
for malaria and were clinically well and apyrexial. By day 15 the
incorporation had improved and there was only a marginally
significant difference from the non-malaria group. The anaemia
of malaria results from the haemolysis of both infected and
uninfected red blood cells, an inflammatory mediated effect on
iron redistribution to reticulo-endothelial macrophages, and an
impaired bone marrow response [11]. Pre-existing iron deficiency
may also influence recovery from post-malaria anaemia. In our
study the inhibitory effect of acute malaria was short-lived and the
erythropoetic response was greater than that of iron deficient
children given supplemental iron.
Acute clinical malaria has been associated with a reduction in
STfR measurement [12] and a rapidly reversible suppression of
bone marrow response to EPO [13]. We found significantly
reduced levels of STfR measurements in the malaria group
indicating reduced erythropoesis, which increased by day 15 to
those levels of the non-malarious group and were reflected in the
haemoglobin response. Erythropoetin measurements were high
and not significantly different between groups on day 1 and
reduced by day 15. During the first 15 days of supplementation a
decrease in EPO measurement in the non-malaria group was
associated with a decrease in STfR measurement whilst in the
malaria group a significantly greater drop in EPO measurement
was associated with an increase in STfR measurements. This may
indicate that iron flux through the reticuloendothelial macrophag-
es and not erythropoetin limits initial erythropoesis in malaria-
associated anaemia. Recycling of senescent red blood cells
normally makes up 90% of erythropoetic iron need with dietary
iron absorption contributing 10% [14]. We found in post-malaria
anaemia that incorporation of supplemental iron was significantly
reduced initially, which may indicate that initial erythropoetic iron
requirements were met through liberation of reticulo-endothelial
iron rather than oral supplemental iron. Comparing these
erythropoetic responses to a third group of anaemic children post
malaria who were not offered oral iron supplementation would
best have tested this, however it was deemed unethical not to
supplement moderately anaemic children in an environment of
endemic iron deficiency. In the absence of this comparator group
we cannot say that supplemental iron had no benefit in the early
recovery phase from post malarial anaemia.
It is not possible from this data to determine whether pre-
existing iron sufficiency differed between the two groups at
baseline as malaria (or the inflammation associated with it) directly
affects both STfR [15] and Ferritin [16]. ZnPP has been reported
to increase with inflammation [17] as well as iron deficiency
however measurements were non-significantly lower in the
malaria group in this study. Iron deficiency and malaria are the
predominate causes of anaemia in this population. Iron deficiency
was present in 87% of the non-malaria group on day 1 and even
after 14 days of supplementation was present in 76% of all the
children at day 15.
Iron absorption is very difficult to measure in the field and red
cell incorporation offers an approximate guide to absorption as
well as flux of iron to erythropoetic cells. We employed this
method in children with malaria as the best available tool to assess
the utility of early iron supplementation in the presence of
inflammation and iron sequestration. Stable isotope iron incorpo-
ration was reduced initially after malaria and the block most likely
occurred during absorption through the small intestinal mucosa.
This may have been either a cytokine/hepcidin mediated effect
and/or possibly resulted from iron loading of the reticuloendo-
thelial macrophages due to malaria. Il-1 and IL-6 regulate
hepcidin transcription in mouse models [18] and human iron
overload results in increased urinary excretion of hepatocyte-
produced hepcidin [19] though the mechanism of iron sensing
and the cell involved remains unclear [20].
57Fe incorporation in
post-malaria anaemia did not correlate with haemoglobin or iron
sufficiency markers except ferritin. Ferritin was most likely a
marker of the overwhelming influence of malaria-associated
inflammation on iron incorporation as ferritin is an acute phase
reactant.
Examining the combined
57Fe and
58Fe incorporation in the
non-malaria group allows for the assessment of influences on iron
incorporation in this population other than malaria. Incorporation
was variable and only inflammation, whz score and ferritin were
independently associated and not age or haemoglobin. We
excluded severely malnourished children (.23 whz scores) from
this study but still found that weight-for-height z-score was
positively correlated with iron incorporation and this effect was
independent of inflammation. This finding is important as it
suggests that poorer whz score is associated with a declining ability
to incorporate supplemental iron. Previous smaller studies [21]
[22] that have tried to address this issue in severely malnourished
children have produced conflicting results often confounded by the
high levels of infection/inflammation in hospitalized subjects.
Supplemental iron given to severely malnourished children early
in rehabilitation is potentially hazardous and not recommended
[23]. Our finding of a decreased capacity to incorporate iron in
less severely malnourished children might represent a protective
mechanism that is further enhanced by inflammation.
Iron deficiency is common in areas of malaria endemicity and
supplementation of young children improves iron status [24]. We
specifically examined the effect of an acute clinical malaria episode
on supplemental iron incorporation and compared the erythro-
poetic response to supplemental oral iron of anaemic children
post-malaria with iron-deficient anaemic children. We demon-
strated an acute depressant effect on iron flux which dissipates
rapidly allowing for an impressive haemoglobin increase despite
reduced supplemental iron incorporation. From this study supple-
mental iron would appear to have had a questionable effect in the
immediate aftermath of malaria when erythropoetic iron need can
only have been met by the release of sequestrated iron. Malaria
results in iron sequestration and reduced iron absorption which
may represent a deliberate mechanism to control iron availability.
Malaria induced haemolysis causes free non-transferrin-bound
iron and free haemoglobin to be released which can cause oxida-
tive stress [25,26] and adding supplemental iron to this milieu may
not improve erythroblastic iron supply.
Distinguishing iron deficiency from iron seqestration immedi-
ately after clinical malaria is very difficult even with access to
laboratory markers of iron status and erythropoesis and is a
common diagnostic dilemma faced by doctors and nurses through-
out malaria endemic areas. Supplemental iron is important to
children with severe post-malaria anaemia if there is a likelihood of
pre-existing iron deficiency. However we have shown that the
utility of supplemental iron given in the first two weeks after a
malarial episode to childen with mild/moderate anaemia is
questionable irrespective of pre-existing iron deficiency. It is likely
that the liberation of sequestered iron is a major source for
erythropoesis in the early stages of recovery from malaria induced
anaemia and re-assessing haemoglobin and/or iron status two
weeks after a malaria episode may well better indicate the need for
supplemental iron at a time when it is more likely to be
incorporated.
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